30 August 2022 – Hilltop Leaf Ltd is pleased to announce that it has successfully completed its first MHRA inspection with no Major or Critical observations following an application for a Manufacturer’s Specials licence in line with The Human Medicines Regulations 2012 (as amended) (SI 2012/1916). The resulting licence will confirm Hilltop Leaf is a…
Read more